Gene Query: SH3BP4

Dataset Description Geneva Score
Transcriptomic analysis of trametinib-resistant HCT116 colorectal carcinoma cells compared to the parental control cells 61.4
Single Cell RNA-Sequencing Identifies Diverse Roles of Epithelial Cells in Idiopathic Pulmonary Fibrosis 59.77
mRNA cap methyltransferase, RNMT-RAM, promotes RNA pol II transcription 53.09
circRNA-sequencing 48.62
Crizotinib v. DMSO in SW480 cells 48.55
Induction of human SST and PV neurons by expressing a single transcription factor LHX6 47.58
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 42.65
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 40.94
Heterozygous and homozygous knock-in of PIK3CA-H1047R into human iPSCs 38.96
Lineage specific differentiation is influenced by state of human pluripotency 35.83
Lineage specific differentiation is influenced by state of human pluripotency [RNA-seq] 35.83
AR-independent prostate cancer is sustained through FGF signaling 34.98
DUX4 recruits p300/CBP through its C-terminus and induces global H3K27 acetylation changes 33.85
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 33.78
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 33.57
Patient-derived luminal breast cancer xenografts with progestins 33.57
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 32.94
mRNA expression in iPS cells generated by a synthetic self-replicative RNA 32.72
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells [RNA-seq] 31.99
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells 31.99
A novel RAF kinase inhibitor with DFG-out binding mode: high efficacy in BRAF-mutant tumor xenograft models in the absence of normal tissue hyperproliferation 29.14
RNA-seq from control and macroH2A1-depleted IMR90 primary human lung fibroblasts 28.54
Exploring the role of macroH2A1 in transcription regulation in IMR90 primary human lung fibroblasts with RNA-seq and ChIP-seq 28.54
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition [RNA-seq] 28.5
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition 28.5
Conversion of Human Fibroblasts to Stably Self-Renewing Neural Stem Cells with a Single Zinc-Finger Transcription Factor 28.44
High-Throughput Drug Screening identifies Pazopanib and Clofilium tosylate as effective treatments for malignant rhabdoid tumors 27.69
Single-cell analysis reveals stochastic regulation of type I IFN production by plasmacytoid dendritic cells and identifies host-derived environmental cues as amplifier of type I IFN production 27.37
α Cell Function and Gene Expression Are Compromised in Type 1 Diabetes 27.06
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [d7+d14] 26.61
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 26.32
RNA-Seq of over-expression and knockdown of the lncRNA SLNCR1 in melanoma cells 25.96
The regulartory role of ZCCHC24 in splicing machinery 25.83
TGF-β promotes genomic instability after loss of RUNX3 25.39
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 25.39
Epigenomic plasticity enables human pancreatic alpha to beta cell reprogramming 24.87
RNA-sequencing of human peripheral blood mononuclear cells (PB MNCs) and induced neural progenitor cells derived from PB MNCs 24.86
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 24.83
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 24.79
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 24.79
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 24.29
Human iPSC-derived glomeruli provide an advanced model to interrogate podocyte biology and accurately recapitulate podocytopathy 23.92
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 23.56
Differential gene expression in Jagged1 treated human dental pulp cells. 22.89
BRD9 defines a novel SWI/SNF sub-complex and constitutes a specific vulnerability in malignant rhabdoid tumors 22.62
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 22.36
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 22.09
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 22.07
Human iPSC-derived cells and microengineered Organ-Chip enhance neural development. 21.97
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons 21.93
A critical but divergent role of PRDM14 in human primordial germ cell fate revealed by inducible degrons [RNA-seq] 21.93
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 21.63
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 21.63
RNA-seq Transcriptome Analysis of AD169 and AD169-ΔUL26 infected MRC5 fibroblasts. 21.52
Differential expression of genes in AD169-infected MRC5. 21.49
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 21.31
NR2F2 study 21.22
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 21.22
DAOY-NERT2 Notch/Hypoxia Transcriptome Analysis 21.08
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 20.97
Transcriptomic and gene ontology profiling of the human corneal cell types 20.66
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 20.59
Genome-wide transcriptional profiling of YAP target genes in human endothelial cells 20.56
Reconstruction of the Human Blood-Brain Barrier in vitro reveals a Pathogenic Mechanism of APOE4 in Pericytes 20.5
Nutritional control of protein translation 20.38
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 20.35
Stimulation of isolated plasmacytoid dendritic cells (pDCs) with TLR9 agonist CpG C (CpG) and TLR7 agonist imiquimod (IMQ) 20.33
Slit2 modifies VEGF-induced angiogenic responses in rabbit skeletal muscle by inducing capillary sprouting and decreasing vascular permeability via reduced eNOS activity 19.91
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 19.76
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 19.76
Rorc disruption in human FG pancreatic cancer cells 19.69
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 19.59
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 19.57
Hypertonic saline attenuates the cytokine-induced pro-inflammatory signature in primary human lung epithelia 19.27
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 19.09
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 19.09
Transcriptomic profiles of human foreskin fibroblast cells in response to orf virus 19.07
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 19.0
Transcriptome analysis of human lung epithelial cells 18.94
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 18.76
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death 18.69
DNA damage signaling mediates the functional antagonism between replicative senescence and terminal muscle differentiation 18.68
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 18.5
In vivo genome editing restores dystrophin expression in Duchenne muscular dystrophy patient muscle fibers 18.49
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 18.19
Transcriptional response to the HSP70 inhibitor MAL3-101 in parental rhabdomyosarcoma cells and isogenic acquired-resistance lines. 18.17
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 18.04
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 17.8
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells (Poly(I:C) and LPS) 17.7
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 17.52
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 17.52
RNA sequencing reveals transcriptional changes after Hippo signaling activation in podocytes 17.42
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 17.25
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 17.01
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 17.0
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 17.0
IDH3a KO RNA-seq 16.91
RNA-seq of cancer cell lines treated with T-025 16.85
The effect of spontaneous acquisition of an extra chromosome 7 for engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 16.71
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 16.5
MYOD Remodeling of the Genome Architecture during Myogenic Conversion of Somatic Cells 16.48
STRIPAK directs PP2A activity to promote oncogenic transformation 16.43
Genome-wide transcriptome profiling of NEDD9-regulated genes using RNA-seq 16.39
Depicting early human development and germ cell origin with porcine embryos 16.24
Expression level comparison under dividing and quiescent states in human primary fibroblasts 16.02
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 15.89
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 15.81
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 15.81
Steroid Receptor Coactivator-2 Regulated Transcriptome in Human Endometrial Stromal Cells 15.78
Alu RNA modulates the expression of cell cycle genes in human fibroblasts 15.76
AUF-1 affected genes in human skin cells 15.65
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 15.46
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma (RNA-seq) 15.45
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma 15.45
Transcriptomic analysis of LSD1 15.0
FOXO1 is required for binding of PR on IRF4, novel transcriptional regulator of endometrial stromal decidualization 14.94
Progesterone receptor transcriptome and cistrome in decidualized human endometrial stromal cells 14.94
Progesterone Receptor- and FOXO1-dependent transcriptomes decidualized human endometrial stromal cells 14.94
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 14.87
Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell-replacement therapy 14.8
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 14.73
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [ZNF787] 14.7
RNAseq Analysis in glioblastoma cells treated with Mepazine 14.66
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 14.57
Transcriptomic profiling of human coronary artery endothelial cells under laminar shear stress (LS), oscillatory shear stress (OS) and static culture (ST) 14.56
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HCT116 cells treated with or without TNF-alpha 14.52
Genome-Wide Transcriptional Effects of the Anti-Cancer Agent Camptothecin 14.44
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 14.4
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis [RNA-Seq] 14.26
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis 14.26
Re-Wiring 3D Nuclear Architecture by a Single Transcription Factor during Somatic Cell Reprogramming 14.23
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 14.15
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 14.05
Differentially expressed genes during pancreatic bud differentiation in cellular aggregates 13.95
VAMP8 contributes to TRIM6-mediated type-I interferon antiviral response upon West Nile virus (WNV) infection 13.87
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 13.87
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 13.81
ARID1A and ARID1B loss in HCT116 cells 13.78
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 13.76
N6-methyladenine DNA Modification in Glioblastoma 13.74
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 13.74
Identification of HOXB13 target genes responsive to BET inhibitors 13.64
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 13.57
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 13.57
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 13.54
Locally transplanted human urine-induced nephron progenitor cells contribute to renal repair in mice kidney with diabetic nephropathy 13.41
Genome-wide functional assessment of enhancer activities in the human genome 13.4
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway [RNA-Seq] 13.29
RC3H1 posttranscriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-kB pathway 13.29
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 13.25
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 13.15
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 13.12
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 13.1
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 13.09
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 13.09
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 13.07
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 13.07
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 13.06
MYOD Gene Expression Regulation during Myogenic Conversion of Fibroblasts 12.99
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 12.94
RNA-seq of human aneuploid cell lines with Trisomy 21 12.92
High-depth RNA sequencing of isogenic wild-type, PIK3CA-WT/H1047R and PIK3CA-H1047R/H1047R human iPSCs 12.87
The mRNA expression analysis of psoriasis skin lesion mesenchymal stem cell 12.8
Gene expression analysis of immortalized human liver progenitor-like cells in culture 12.57
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells 12.56
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 12.55
Transcriptomic profiling of mesenchymal stem cells (MSC) differentiation into mesangial cells 12.54
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 12.52
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 12.52
Transcriptome of iPSC-derived Neural Cells with Heterozygous Knockout in CHD8 12.51
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 12.5
Gene expression profile of HGC27 and LMSU gastric cancer cell p53 KO and KD 12.42
Ex vivo expanded human 3D Nephrospheres engraft long term and repair chronic renal injury in mice 12.41
RNA sequencing to compare gene expession in control and PF228-treated hepatic stellate cells 12.39
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 12.31
Non-coding regions are the main source of tumor-specific antigens [human] 12.27
Non-coding regions are the main source of tumor-specific antigens 12.27
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 12.25
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 12.25
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 12.19
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 12.19
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 12.05
RNA Sequencing of default, melanocyte biased and enteric human neural crest populations (NC) and neuroectoderm (CNS) 12.03
Gene expression changes upon drug withdrawal (Mel888 cell line) 12.02
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens 12.0
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens [RNA-Seq] 12.0
Genome-wide Analysis of Human Constitutive Androstane Receptor (CAR) Transcriptome in Wild-type and CAR-knockout HepaRG cells 11.99
Synaptic dysfunction in human neurons with Autism associated deletions in PTCHD1-AS 11.96
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 11.95
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 11.95
RNA-seq differential expression studies: more sequence, or more replication? 11.92
High-throughput RNAi cell viability screen to identify selective targets for EWS-FLI1 positive Ewing sarcoma 11.91
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 11.88
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 11.87
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) 11.87
Transcriptome analysis of kidney organoids 11.81
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics 11.78
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics (RNA-Seq) 11.78
Transcriptome changes due to nuclear penetration of cancer extracellular vesicles 11.72
Gene expression profiling of human and murine in vitro muscle differentiation 11.69
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 11.67
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 11.67
RNA-seq in transgenic cells 11.62
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 11.62
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 11.61
MondoA Links Muscle Lipid Accumulation and Insulin Resistance Driven by Nutrient Overload 11.54
Transcriptome profiling in primary human skeletal myotubes with MondoA knockdown 11.54
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 11.51
Transcriptome-wide analysis of adipose circular RNAs reveals their dynamic regulation in obesity and functional role in adipogenesis 11.47
Induced pluripotent stem cell modeling of bone marrow failure and MDS identifies therapeutic targets 11.45
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 11.44
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 11.44
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 11.43
Maturation of human iNSCs 11.42
Temporal dynamic reorganization of 3D chromatin in hormone-induced breast cancer and endocrine resistance 11.39
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 11.36
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 11.36
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 11.36
G-quadruplex structures mark human regulatory chromatin 11.22
Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq 11.21
RNA-Seq from early time points in the kidney differentiation protocol 11.18
RNA sequencing of human fibroblasts after SUPT4H1 siRNA treatment 11.14
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 11.12
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 11.1
Transcriptome analysis of Zika infected neural stem cells 11.07
Zika infected neural stem cells 11.07
Identification of Sin3B regulated genes during quiescence 11.03
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 11.0
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 10.99
Identification of long noncoding RNAs regulated by p53 10.99
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 10.97
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 10.92
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 10.89
FUS mutant human motoneurons transcriptome analysis reveals altered pathways and impairment of microRNA function 10.85
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 10.84
Functional Cardiac Fibroblasts Derived from Human Pluripotent Stem Cells via Second Heart Field Progenitors 10.84
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 10.83
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 10.81
RNA-Seq Analysis in hES/ iPS cell-derived neuronal samples 10.8
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 10.8
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 10.76
TGF-β regulation of miRNA expression in pancreatic cancer 10.75
NGS based identification of GD2-positive tumor-specific phenotype for cancer diagnostics and therapy 10.73
Expression changes in melanoma cell lines pre MAPKi treatment vs. post-MAPKi resistance (RNA-seq_CellLine.batch2) 10.68
The effect of Foxc1 deficiency on undifferentiated and differentiated human primary keratinocytes 10.59
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 10.59
SMN deficiency in spinal muscular atrophy causes widespread intron retention and DNA damage 10.58
Temporal activation of NR5A2 and RARγ induce functional human naïve pluripotent state via modulating TGFβ pathway 10.57
MEIS1 regulates hematopoiesis in hPSCs 10.57
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 10.56
Osteogenic programming of adipose-derived mesenchymal stem cells using a fungal metabolite that suppresses the Polycomb protein EZH2 10.5
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 10.46
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation [mRNA-Seq] 10.45
Integrated Profiling of mRNAs and microRNAs to Identify Potential Biomarkers for Oral Malignant Transformation 10.45
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 10.44
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 10.37
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 10.37
Identification of the role of polydom in neurofibromas 10.35
Sequencing-based analyses characterize a tumor suppressive role of mir-1271 repressed by DNA hypermethylation in gastric cancer 10.3
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 10.28
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 10.24
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 10.24
Generation of induced neural stem cells from urine derived cells by synthetic mRNA 10.15
Gene expression profiling of iPSC-derived cardiomyocytes with BAG3 mutations 10.01
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [polyA RNA-seq] 10.01
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 10.01
An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cell 9.98
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas 9.91
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines HSB2 and RPMI8402 9.86
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 9.85
Runx1 stabilizes the mammary epithelial cell phenotype and prevents epithelial to mesenchymal transition 9.83
OBESITY IS ASSOCIATED WITH IMPAIRED EXPRESSION OF THE GLYCOSYLTRANSFERASE EOGT IN DECIDUALIZING ENDOMETRIUM 9.71
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 9.7
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 9.66
Transcriptome profiling of CXCR2+ neuroendocrine (NE) tumor cells purified from patients' fresh prostate adenocarcinoma 9.66
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 9.6
Effect of BET bromodomain inhibition with JQ1 in stressed human derived iPS cardiomyocytes 9.6
BET bromodomain inhibition 9.6
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 9.59
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 9.54
Allelic expression mapping across cell lineages reveal repressor disruption among disease SNPs 9.53
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 9.47
The Promyelocytic Leukemia Zinc Finger Dependent Transcriptome during Human Endometrial Stromal Cell Decidualization 9.4
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 9.37
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 9.36
Novel Targeting of Transcription and Metabolism in Glioblastoma 9.34
Identification of genes regulated by Long noncoding RNA H19 in hepatic cells 9.34
H19 regulates hepatic glucose production by epigenetic modification of Hnf4* 9.34
PRDM1 inhibits proliferation of human colon cancer organoids 9.33
SNHG5 siRNA knock down in HCT116 cells 9.27
Chronophin regulates metabolic and transcriptomic features of glioblastoma stem-like cells 9.24
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 9.18
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 9.17
Effect of CHKA knockdown on C4-2 cell transcriptome 9.14
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 9.09
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 9.05
Involvement of Condensin in Cellular Senescence through Gene Regulation and Compartmental Reorganization 9.01
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 9.01
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC 8.99
Discovery of a Drug Candidate for GLIS3-Associated Diabetes 8.99
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 8.96
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 8.96
Gene expression analysis of human haploid cells (HAP1) depleted of SMARCB1 and SMARCA4 8.96
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 8.92
Selective suppression of endothelial cytokine production by progesterone receptor [RNA-seq] 8.85
Selective suppression of endothelial cytokine production by progesterone receptor 8.85
4sU-seq of HFF exposed to salt and heat stress 8.83
Effect of drugs on transcriptomic profiles 8.81
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 8.73
Modeling Familial Cancer with iPSC Approaches 8.72
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 8.7
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 8.7
The landscape of alternative splicing in aggressive prostate cancers 8.59
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 8.57
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 8.55
Molecular pathogenesis of human prostate basal cell hyperplasia reveals a keratinocyte metaplasia 8.48
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 8.48
Genome wide miR-191 target profile determined by RIP and gene expression profiling 8.4
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 8.4
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 8.4
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 8.4
A practical evaluation of alignment algorithms for RNA variant calling analysis 8.37
SLIGRL-induced gene expression changes in NHEK cells 8.34
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 8.33
CDK4/6 inhibitor resistance in prostate cancer 8.29
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 8.28
Expression data for KDM1B knockdown in Glioma-Initiating Cells (GICs) 8.12
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction 8.11
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 8.09
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 8.09
Human HAP1 cells before and after nutrient deprivation 8.08
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 8.08
RNAseq of cell lines with knocked in ESR1 mutations 8.02
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 7.94
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 7.94
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 7.92
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 7.84
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 7.79
Identification of an IL-1-induced gene expression pattern in AR+ PCa cells that mimics the molecular phenotype of AR- PCa cells 7.77
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 7.75
Transcriptomic Profiling of Developing Human Paraxial Mesoderm from 4.5-5 Weeks of Gestation Human Embryos 7.74
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 7.72
Modulation of mitochondrial DNA copy number to induce hepatocytic differentiation of human Amniotic Epithelial cells 7.7
KSHV vIRF3 promotes angiogenesis of lymphatic endothelial cells (LECs) 7.68
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 7.68
Functional role of CPPED1 in trophoblasts. 7.6
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 7.56
Replication defective viral products exploit a cellular pro-survival mechanism to establish persistent infections 7.53
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 7.4
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 7.27
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 7.22
Characterization and therapeautic application of mesenchymal stem cells with neuromesodermal origin from human pluripotent stem cells 7.22
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 7.19
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 7.18
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 7.14
Zika virus infection reprograms global transcription of host cells to allow sustained infection 7.08
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 7.05
The Genomic Landscape of Atypical Fibroxanthoma 7.03
SHANK2 mutations associated with autism spectrum disorder cause hyperconnectivity of human neurons 6.97
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 6.93
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier [human] 6.89
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier 6.89
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 6.89
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 6.81
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 6.6
Browning of human adipocytes requires KLF11 and reprogramming of PPARγ super-enhancers 6.57
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 6.43
TFAP2C signalling in human fibroblasts 6.42
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 6.42
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 6.39
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 6.39
Illumina Total RNA-seq in HeLa 6.38
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 6.31
Genome-wide DNA accessibility maps and differential gene expression using ChIP-seq, ATAC-seq and RNA-seq for the human secondary fibroblast cell line hiF-T and whole worms with and without knockdown of FACT complex 6.29
Gene expression profiling of KSHV-infected periodontal ligament cells 6.28
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 6.25
RNA sequencing of mechanically strained NHEKs and control NHEKs 6.2
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 6.19
PGE2 mediated gene expression changes in human cervical stromal cells 6.18
Toxoplasma gondii infection of human retinal pigment epithelial cells 6.18
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 6.15
Effects of darunavir upon gene expression in kidney tubular cells after transduction with HIV or EGFP-control lentivirus 6.15
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 6.07
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 5.89
RNA-seq of H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 5.87
H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 5.87
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 5.79
Transcriptome analyses of iPSC-derived neural stem/progenitor cells and cerebral organoids from monozygotic twins discordant for schizoaffective bipolar disorder 5.71
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 5.61
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 5.61
Transcriptome-wide response to synthetic chromatin protein PcTF 5.57
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 5.47
Genes encoding cognate receptors for IRI-related recipient cytokines are expressed in donor livers 5.43
Analysis of MGE Transcriptomes with or without Ctnnb1 knockout in human through RNA Sequencing 5.29
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 5.27
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 5.22
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 5.12
Fixed tissue ChIP-Seq (FiT-Seq) of archived clinical samples reveals chromatin dynamics and tumor-specific enhancer profiles 5.11
CDK12 mediated transcriptional regulation in U2OS cells 5.1
Copper Regulation of HIF-1 Transcription Activity 5.09
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 5.09
Isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 5.02
CD13 and ROR2 permit isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 5.02
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 5.01
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 4.96
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 4.96
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 4.81
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 4.75
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 4.59
RNA-seq in neurons derived from iPSCs in controls and patients with schizophrenia and 22q11 del 4.52
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 4.52
Comparison of microRNA Profiling Platforms (HTS) 4.46
Comparison of microRNA Profiling Platforms 4.46
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 4.4
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. 4.39
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor [human RNA-seq] 4.39
Capturing the Interactome of Newly Transcribed RNA (RICK) 4.29
Capturing the Interactome of Newly Transcribed RNA 4.29
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 4.29
RNA-Seq profiling of iPSC-derived ventricular and atrial cardiomyocytes 4.25
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 4.22
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 4.22
Small-molecule targeting of brachyury transcription factor addiction in chordoma 4.11
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 4.05
Metabolism as an early predictor of DPSCs aging 4.01
MEK inhibition rewires enhancer landscapes in RAS-driven Rhabdomyosarcoma to unlock a myogenic differentation block 3.96
Epigenetic Reprogramming of mutant RAS-driven Rhabdomyosarcoma via MEK Inhibition 3.96
Profiling gene expression changes in ovarian cancer cells seeded on 3D organotypic culture of omentum 3.96
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 3.89
Genome-wide RNA-sequencing of human islets 48 hour after transduction with adenoviruses expressing either GFP (control), or histone chaperone ASF1B. 3.83
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of AIM2. 3.81
Leucegene: ALL sequencing 3.79
m6A-dependent regulation of messenger RNA stability 3.72
RNA-seq analysis of hPSC-derived brain pericyte-like cells, hPSC-derived neural crest stem cells, and primary human brain pericytes 3.59
Spatial proximity to fibroblasts impacts molecular features and therapeutic sensitivity of breast cancer cells influencing clinical outcomes 3.57
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 3.41
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 3.4
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 3.35
Cell cycle positioning drives heterogeneity within the pluripotent stem cell compartment 3.27
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 3.24
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 3.24
RNAseq of Breast cancer PDX samples 3.17
Effect of ILF3 depletion in HeLa cells on RNA steady state levels 3.14
Transcriptomic analysis of ERR alpha orphan nuclear receptor 2.98
Efficient derivation of microglia-like cells from human pluripotent stem cells 2.97
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 2.93
ARID1A and ARID1B loss in HCT116 and TOV21G cells 2.9
Transcriptome of EBV-infected gastric cancer cell lines 2.81
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 2.8
RNA-sequencing of tamoxifen-resistant and -sensitive breast cancer cell lines. 2.74
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 2.6
Human islets of varying quality: the good, the (not so) bad and the ugly 2.56
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 2.47
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 2.45
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 2.43
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 2.43
Transcriptional Profiling of Werner Syndrome (WS) iPSC-derived MSC and the isogenic gene-edited controls 2.35
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 2.28
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 2.12
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 2.1
Transcriptome profiling of omental adipose tissues in human obesity by RNA-Seq 2.08
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 1.94
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 1.9
ETS1 acts as a tumor suppressor in breast cancer by inhibiting growth-related factors 1.85
RNA sequencing analysis of selumetinib-resistant CRC cells lines 1.73
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 1.64
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 1.52
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 1.38
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 1.34
Characterisation of the EZH2 regulated transcriptome in de novo transformed cells (RNA-Seq) 1.19
A systematic analysis of the time series gene expression in TGF-beta induced EMT by Next-generation sequencing 1.1
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 1.09
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 1.09
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 1.06
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 1.06
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment [RNA-Seq] 1.05
Rapid Irreversible Transcriptional Reprogramming in Human Stem Cells Accompanied by Discordance between Replication Timing and Chromatin Compartment 1.05
Dermal endothelial cells of type 2 diabetic patients 0.95
6mer seed toxicity in viral microRNAs 0.93
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 0.93
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. 0.92
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. [RNA-Seq] 0.92
Restoration of Progranulin Expression Rescues Cortical Neuron Generation in Induced Pluripotent Stem Cell Model of Frontotemporal Dementia 0.9
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI 0.57
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 0.52
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 0.48
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 0.48
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 0.48
RNA-seq of HUVEC ± shRNA knockdown of SENCR 0.47
Transcriptome profiling of influenza virus-infected human bronchial epithelial cells 0.46
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 0.42
Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia and facial dysmorphism 0.36
Vammin induces a highly efficient angiogenic response through VEGFR-2/NRP-1 and bypasses the regulatory function of VEGFR-1 0.23
BMS-470539 on human synovial fibroblasts 0.18
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 0.14
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 0.09
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 0.04
Patient-derived xenograft platform for metastatic melanoma: a model for studying resistance to targeted therapy. 0.01
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.01
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation